Please provide your email address to receive an email when new articles are posted on . The FDA based sotatercept's/Winrevair’s approval on data from the phase 3 ...

Pulmonary rehabilitation, an essential component of care for patients with chronic respiratory conditions, is difficult for millions of Americans to access, a new Yale-led study reveals. The findings, ...

Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic thromboembolic pulmonary hypertension, with specific patient selection ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Hyperventilation is common in EMS. Pulmonary embolism (PE) is not. That imbalance creates risk. Experience teaches us to ...